PRESENCE AND STRENGTH OF BINDING ANTIBODY PROFILES AGAINST SARS-COV-2 DURING COVID-19 INFECTION
Dr.ir. Richard Schasfoort
Recorded during: The 2020 TechMed Event | more info
Date recording: 10 September 2020
Abstract
Surface Plasmon Resonance imaging (SPRi) was used to determine the presence and strength of binding of IgG, IgM and IgA against the Receptor Binding Domain (RBD) of SARS-CoV-2 in sera of 119 CoViD-19 patients. The high-throughput assay enables to follow the specific immune response of ultimate 384 individuals for these four parameters in one run. During the course of the disease, the IgG levels and strength of binding increased while generally the IgM and IgA levels went down. Recovered patients all show high strength of binding of the IgG type to the RBD protein. The SPRi assay provides additional insights in the immune status of patients recovering from CoViD-19 and can be applied for the assessment of the immune reaction of healthy individuals in vaccination programs.